Cover Image

Annual report.

Bibliographic Details
Corporate Author:	Center for Drug Evaluation and Research (U.S.). Office of Drug Safety
Format:	Government Document Serial
Language:	English
Published:	Rockville, Md. : Center for Drug Evaluation and Research, Food and Drug Administration, -[2004]
Subjects:	Center for Drug Evaluation and Research (U.S.). > Office of Drug Safety > Periodicals. Drugs > United States > Periodicals.
Online Access:	https://purl.fdlp.gov/GPO/LPS81029

Similar Items

Annual adverse drug experience report.

Improving public health : promting safe and effective drug use.
Published: (2003)

Manual del Centro para la Evaluacion e Investigacion de Farmacos.
Published: (2001)

CDER ... report to the nation : improving public health through human drugs /
Published: (1998)

CDER ... report to the nation /
Published: (1998)

Mejorando la salud pública : fomentando la venta y el uso de drogas efectivas.
Published: (2003)

Report to industry.
Published: (1997)

Center for Drug Evaluation and Research update.

The CDER reference guide.

Management of information technology contracts at the Food and Drug Administration's Center for Drug Evaluation and Research.
Published: (2009)

Annual report.
Published: (2003)

Guidance for industry : granularity document : annex to M4, organization of the CTD.
Published: (2005)

Guidance for industry : providing regulatory submissions in electronic format : human pharmaceutical product applications and related submissions using the eCTD specifications.
Published: (2008)

Guidance for FDA staff and industry : marketed unapproved drugs, compliance policy guide.
Published: (2006)

FY ... performance report to the President and the Congress for the Prescription Drug User Fee Act of 1992 as reauthorized and amended by the Food and Drug Administration Modernization Act of 1997 and the Public Health Security and Bioterrorism Preparedness and Response Act of 2002.

Guidance for industry : drug-induced liver injury, premarketing clinical evaluation.
Published: (2009)

Guidance for industry : how to comply with the Pediatric Research Equity Act.
Published: (2005)

NIJ annual report.

FY ... ADUFA financial report required by the Animal Drug User Fee Act of 2003.
Published: (2004)

Rare disease drugs : FDA has steps underway to strengthen coordination of activities supporting drug development : report to congressional committees /
Published: (2024)

A counterdrug research and development blueprint update.

Review of U.S. Immigration and Customs Enforcement's reporting of FY ... drug control performance summary report /
Published: (2013)

Performance report to Congress for the Animal Drug User Fee Act.
Published: (2005)

FY ... performance report to the Congress for the Animal Drug User Fee Act.
Published: (2003)

Annotated bibliography of papers from the Addiction Research Center, 1935-75.
Published: (1978)

Review of U.S. Customs and Border Protection's FY ... drug control performance summary report /
Published: (2015)

Independent review of the U.S. Customs and Border Protection's reporting of FY ... drug control obligations.

Independent review of the U.S. Customs and Border Protection's reporting of FY ... drug control performance summary /
Published: (2008)

Un centro de la FDA al frente de investigación biomolecular.
Published: (2002)

Alimentos seguros : cómo lo logra un equipo.
Published: (2001)

Arrestee Drug Abuse Monitoring Program II ... annual report.

FY ... accounting of drug control funds and performance summary.

FY ... accounting of drug control funds.

Food and Drug Administration management concerns : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, second session, April 1, 1998.
Published: (1998)

Performance measures of effectiveness : ... report.

Postmarketing studies of prescription drugs.
Published: (1996)

Annual performance report /

West Texas HIDTA ... annual report.

Annual report of the Organized Crime Drug Enforcement Task Force Program.
Published: (1984)

Perspectives in drug discovery and design : PD3.
Published: (1993)